[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2021103268A4 - Two-component polyurethane composition and its preparation method, and application thereof - Google Patents

Two-component polyurethane composition and its preparation method, and application thereof Download PDF

Info

Publication number
AU2021103268A4
AU2021103268A4 AU2021103268A AU2021103268A AU2021103268A4 AU 2021103268 A4 AU2021103268 A4 AU 2021103268A4 AU 2021103268 A AU2021103268 A AU 2021103268A AU 2021103268 A AU2021103268 A AU 2021103268A AU 2021103268 A4 AU2021103268 A4 AU 2021103268A4
Authority
AU
Australia
Prior art keywords
component
polyurethane composition
component polyurethane
crosslinking agent
polyol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2021103268A
Inventor
Yun Bai
Bin He
Yabin ZHU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Baoting Biotechnology Co ltd
Original Assignee
Ningbo Baoting Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo Baoting Biotechnology Co Ltd filed Critical Ningbo Baoting Biotechnology Co Ltd
Priority to AU2021103268A priority Critical patent/AU2021103268A4/en
Application granted granted Critical
Publication of AU2021103268A4 publication Critical patent/AU2021103268A4/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07Stiffening bandages
    • A61L15/12Stiffening bandages containing macromolecular materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

The invention provides a two-component polyurethane composition, belonging to the technical field of polymer materials. The two-component polyurethane composition comprises component A and component B. According to the mass percentage, the component A comprises 0-100% of high-activity polyether polyols, 0-100% of cross linking agent, 0-40% of chain extender, 0-50% of plasticizer and 0-5% of catalyst. According to the mass percentage, the component B comprises 0-100% of diphenylmethane diisocyanate and derivatives thereof, and 0-50% of plasticizer. The mass ratio of component A to component B is 1:0.1-1:3. The two-component polyurethane composition provided by the invention has low heat release and excellent mechanical properties.

Description

Two-component polyurethane composition and its preparation method, and application thereof
TECHNICAL FIELD
This invention relates to technical field of polymer materials, particularly relates to two-component polyurethane composition and its preparation method, and application thereof.
BACKGROUND
Fracture fixation splint is a commonly used auxiliary equipment in orthopedic treatment. At present, in clinical treatment, plaster and splint are used to treat bone injury patients. Traditional plaster and splint fixation method has poor air permeability and high hardness, which may cause itching, friction pain, dermatitis and other problems due to sultry heat during use. Moreover, its high hardness makes skin tightly squeezed, which causes skin necrosis, long-term inflammation and other problems, resulting in poor satisfaction of patients. In addition, the first symptom when fracture occurs is swollen on the area of fraction, this symptom gradually subsides during the healing process. High hardness gypsum board or splint has no adjustment function, it can only be replaced with new material, which not only wastes resources but increases the economic burden of patients.
In addition to the traditional plaster fixation method, in clinic, polymer splint is used to fix the wounded area for treatment. The bandage coated with waterborne one component polyurethane material is commonly used, which needs to be soaked in water, wrung out, molded and applied to the patient for setting. It is characterized by light weight, high hardness, non-elasticity, etc, however, it is inconvenient to use, and has poor air permeability, and it causes poor physical sensation, sultriness and itch to patience.
SUMMARY
In view of this, one of the aims of the present invention is to solve the shortcomings in the above-mentioned background art, therefore, this invention provides two component polyurethane composition provided by the invention has low heat release and excellent mechanical properties.
In order to achieve the above purpose, this invention provides the technical solutions as below:
According to the mass percentage, the component A comprises 0-100% of high activity polyether polyols, 0-100% of cross-linking agent, 0-40% of chain extender, 0 % of plasticizer and 0-5% of catalyst.
According to the mass percentage, the component B comprises 0-100% of diphenylmethane diisocyanate and derivatives thereof, and 0-50% of plasticizer. The mass ratio of component A to component B is 1:0.1-1:3.
The mass ratio of component A to component B is 1:0.1-1:3.
Preferably, polyether polyol is a kind of polyoxypropylene polyol and polytetrahydrofuran polyol and polybutylene oxide polyol.
Preferably, the macromolecular crosslinking agent is polyether polyol with high functionality, which prefers to one of MN500, MN700 andMN1000.
Preferably, the micromolecule crosslinking agent is multifunctional micromolecule polyol, preferably at least one of tetrahydroxypropylethylenediamine, pentaerythritol, trimethylolpropane, glycerol and tetrahydroxypropylethylenediamine.
Preferably, the chain extender is small molecule diol, preferably at least one of diethylene glycol, ethylene glycol and dipropylene glycol.
Preferably, the catalyst is an amine catalyst or a metal salt catalyst.
Preferably, plasticizers in component A and component B include at least one of cyclohexane 1,2-diisononyl phthalate, triethyl citrate, dibutyl phthalate, dioctyl sebacate, acetyl tributyl citrate and 2,2,4- trimethyl -1,3- pentanediol diisobutyrate.
The other purpose of this invention is to provide the preparation method of the above two-component polyurethane composition, which comprises the following steps:
Preparation of component A
Adding measured component a into a disperser, stirring to obtain viscous liquid, drying and stirring it for later use.
Preparation of component B
Adding metered diphenylmethane diisocyanate and its derivatives and dried plasticizer into a dispersing machine, and stirring it to form viscous liquid for later use.
The preparation of two-component polyurethane composition
Packaging the prepared component A and component B in aluminum foil bags respectively for later use.
Pouring the component B into the aluminum foil bag of the component A, shaking and mixing it evenly, and squeezing it into the matching silica gel bag to get the final product;.
Preferably, the inner cavity of the silica gel bag is covered with an inner bag, so that the silica gel bag has anti-bursting function.
The third purpose of this invention is to provide the application of two-component polyurethane composition in orthopedic treatment.
Compared with the prior art, the invention has the following beneficial effects:
1. This invention provides two-component polyurethane composition that has low heat release and excellent mechanical properties.
2. The two-component polyurethane composition provided by the invention can be applied to auxiliary equipment that commonly used in orthopedic treatment, such as polymer splint. Because the two-component polyurethane composition has elasticity, soft silica gel surface that is skin-friendly, it can be set into cavities with various shapes according to needs, which can mitigate the problems of sweltering heat, itching and poor air permeability of patients, and has the advantages of elasticity, appropriate adjustment and tightness to increase the comfort of patients.
DESCRIPTION OF THE INVENTION
In order to make the objectives, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions of the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without creative labor belong to the scope of protection of the present invention. Therefore, the following detailed description of embodiments of the present invention is not intended to limit the scope of the claimed invention, but only represents selected embodiments of the present invention.
Two-component polyurethane composition comprises component A and component B:
According to the mass percentage, the component A comprises 0-100% of high activity polyether polyols, 0-100% of cross-linking agent, 0-40% of chain extender, 0 % of plasticizer and 0-5% of catalyst.
According to the mass percentage, the component B comprises 0-100% of diphenylmethane diisocyanate and derivatives thereof, and 0-50% of plasticizer.
The mass ratio of component A to component B is 1:0.1-1:3.
Polyether polyol (polyether for short) is an organic polymer, which is prepared by ring-opening reaction of initiator (compound containing active hydrogen group) with ethylene oxide (EO), propylene oxide (PO), butylene oxide (BO), etc. in the presence of catalyst.
According to this invention, the polyether polyol is a kind of polyoxypropylene polyol, polytetrahydrofuran polyol and polybutylene oxide polyol.
In the present invention, the cross-linking agent includes at least one of macromolecular cross-linking agent and micromolecule cross-linking agent. Because the micromolecule cross-linking agent makes the product hard and brittle, and the product prepared by macromolecular cross-linking agent has certain toughness. The embodiments described in the present invention show that macromolecular cross-linking agent and micromolecule cross-linking agent are added simultaneously.
In the present invention, the macromolecular crosslinking agent is a polyether polyol with high functionality, preferably one of MN500, MN700 and MN1000, which can be selected by a person skilled in the art according to actual needs.
In the present invention, the small molecule crosslinking agent is a multifunctional small molecule polyol, preferably at least one of tetrahydroxypropylethylenediamine, pentaerythritol, trimethylolpropane, glycerol and tetrahydroxypropylethylenediamine, which can be selected by a person skilled in the art according to actual needs.
In the present invention, the chain extender is a small molecule diol, preferably at least one of diethylene glycol, ethylene glycol and dipropylene glycol, which can be selected by a person skilled in the art according to actual needs.
Preferably, the catalyst is an amine catalyst or a metal salt catalyst, which can be selected by a person skilled in the art according to actual needs. In the present invention, plasticizers in component A and component B include at least one of diisononyl cyclohexane 1,2-dicarboxylate, triethyl citrate, dibutyl phthalate, dioctyl sebacate, acetyl tributyl citrate and 2,2,4- trimethyl -1,3- pentanediol diisobutyrate.
The invention provides a preparation method of the two-component polyurethane composition, which comprises the following steps:
Respectively adding metered component A into a high-speed disperser, stirring at high speed for 0.5-6 hours to form viscous liquid with viscosity of 200 ~
OOmPa-s/25°C, adding 2-30% by mass of molecular sieve, stirring it at low speed for 72 hours for later use, or dehydrating at high temperature for later use.
Preparation of two-component polyurethane composition
Packaging the prepared component A and component B in aluminum foil bags respectively for later use. Pouring the component B into the aluminum foil bag of the component A, shaking and mixing it evenly for 1 minute, then squeezing it into the matching silica gel bag, and curing it for about 10 minutes to obtain two-component polyurethane composition.
Preferably, the inner cavity of the silica gel bag is covered with an inner bag for anti bursting function,it can prevent the inner liquid from overflowing due to bursting or breakage when the A\B glue is poured.
The invention also provides the application of the two-component polyurethane composition in orthopedic treatment, for example, using the two-component polyurethane composition to prepare auxiliary equipment in orthopedic treatment, and the specific example is: preparing the fracture fixing plate described in the background art, and opening holes on its surface. The two-component polyurethane composition has the advantages of elasticity, soft silica gel surface that is skin-friendliness, and can be set into cavities with various shapes as required, which can mitigate the problems of sweltering heat, itching and poor air permeability of patients, and it has the advantages of elasticity, proper adjustment and tightness to increase the comfort of patients. More importantly, doctors can observe the condition of bone injury through hollow eyes, and can also check the healing of the affected area through X-ray, CT and other instruments to provide convenience for doctors' treatment plans.
The present invention will be further explained in detail with specific embodiments.
The brand names are introduced as follows, and the chemical components in the invention are exemplified by the following brands
330N Multifunctional soft foam polyether
DV125 Multifunctional macromolecular crosslinking agent
MN500 Multifunctional macromolecular crosslinking agent
MN700 Multifunctional macromolecular crosslinking agent
MN1000 Multifunctional macromolecular crosslinking agent
EDTP Multifunctional micromolecular crosslinking agent
EG Multifunctional micromolecular crosslinking agent
TMP Multifunctional micromolecular crosslinking agent
TIPA Multifunctional micromolecular crosslinking agent
DEG Chain extender
TXIB Plasticizer Polymethylene polyphenyl polyisocyanate PAPI (crude MDI)
Liquefied MDI Diphenyl methane diisocyanate derivatives
Amine catalyst A33
4110 Metal salt catalyst
Embodiment 1
Composition Name Mass percentage 330N 30% DV125 15%
A component EDTP 20% DPG 5%
TXIB 30% Liquefied MDI 30% B component PAPI 30% TXIB 40%
Package the A and B components in Example 1 in aluminum foil bags according to the mass ratio of 1:1.2, and place them in a dry and cool environment for later use.
Method: for using, pouring the B component into the aluminum foil bag of the A component, shaking and mixing it evenly for one minute, then squeezing it into the matching silica gel bag, and curing it in about 10 minutes.
The main technical indicators are as follows:
Number Item Unit Index
A component:
680 1 Appearance mPa-s/25°C B component
260
2 Density g/cm 3 1.12
3 Hardness Shore Type D 75
4 Gel time min 2
5 Curing time min 10
Peak 6 0C 55 temperature
Embodiment 2-7 described as below
Embodiment Embodiment Embodiment Embodiment Embodiment Embodiment Composition Name 2 3 4 5 6 7
330N 20% 40% 60% 80% 30% 40%
DV125 25% 15% 15%
MN500 10%
MN700 10%
MN1000 5%
EDTP 20% 15%
Component EG 10% 4.98%
A TMP 20%
TIPA 15%
DEG 4.98% 4.98% 4.98% 4.98% 4.98%
A33 0.02% 0.02% 0.02% 0.02%
4110 0.02% 0.02%
TXIB 30% 30% 15% 10% 30% 25%
Component PAPI 25% 25% 30% 30% 30% 30% B TXIB 50% 50% 40% 40% 40% 40%
Liquefied 25% 25% 30% 30% 30% 30% MDI
Mass Ratio 1:1.68 1:1.11 1:1.24 1:0.58 1:1.69 1:1.19
Item Unit Formula 2 Formula 3 Formula 4 Formula 5 Formula 6 Formula 7
A:680 A:750 A:800 A:760 A:780 A:770 mPa-s/25 Appearance C B:230 B:230 B:260 B:260 B:230 B:260
Density g/cm3 1.18 1.18 1.12 1.16 1.16 1.16
Shore Hardness 70 68 75 72 74 72 Type D
Gel time min 2.5 2.8 2 2.5 2.5 2.5
Curing time min 13 13 11 13 13 15
Peak aC 55 55 57 60 58 52 temperature

Claims (10)

THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:
1. Two-component polyurethane composition is characterized in comprising component A and component B:
According to the mass percentage, the component A comprises 0-100% of high activity polyether polyols, 0-100% of cross-linking agent, 0-40% of chain extender, 0 % of plasticizer and 0-5% of catalyst.
According to the mass percentage, the component B comprises 0-100% of diphenylmethane diisocyanate and derivatives thereof, and 0-50% of plasticizer. The mass ratio of component A to component B is 1:0.1-1:3.
The mass ratio of component A to component B is 1:0.1-1:3.
2. Two-component polyurethane composition, according to claim 1, is characterized in that the polyether polyol is a kind of polyoxypropylene polyol and polytetrahydrofuran polyol and polybutylene oxide polyol.
3. Two-component polyurethane composition, according to claim 1, is characterized in that the crosslinking agent comprises at least one of macromolecular crosslinking agent and micromolecule crosslinking agent.
4. Two-component polyurethane composition, according to claim 3, is characterized in that the macromolecular crosslinking agent is polyether polyol with high functionality, preferably, it is one of MN500, MN700 and MN1000.
5. Two-component polyurethane composition, according to claim 3, is characterized in that the micromolecule crosslinking agent is multifunctional micromolecule polyol, preferably at least one of tetrahydroxypropylethylenediamine, pentaerythritol, trimethylolpropane, glyceroland tetrahydroxypropylethylenediamine.
6. Two-component polyurethane composition, according to claim 1, is characterized in that the chain extender is small molecule diol, preferably at least one of diethylene glycol, ethylene glycol and dipropylene glycol.
7. Two-component polyurethane composition, according to claim 1, is characterized in that the catalyst is an amine catalyst or a metal salt catalyst.
8. Two-component polyurethane composition, according to claim 1, is characterized in that plasticizers in component A and component B include at least one of cyclohexane 1,2-diisononyl phthalate, triethyl citrate, dibutyl phthalate, dioctyl sebacate, acetyl tributyl citrate and 2,2,4- trimethyl -1,3- pentanediol diisobutyrate.
9. The preparation method of two-component polyurethane composition, according to any claim from claim 1 to 8 is characterzied in comprising the following steps:
Preparation of component A
Adding measured component a into a disperser, stirring to obtain viscous liquid, drying and stirring it for later use.
Preparation of component B
Adding metered diphenylmethane diisocyanate and its derivatives and dried plasticizer into a dispersing machine, and stirring it to form viscous liquid for later use.
The preparation of two-component polyurethane composition
Packaging the prepared component A and component B in aluminum foil bags respectively for later use.
Pouring the component B into the aluminum foil bag of the component A, shaking and mixing it evenly, and squeezing it into the matching silica gel bag to get the final product;.
Preferably, the inner cavity of the silica gel bag is covered with an inner bag, so that the silica gel bag has anti-bursting function.
10. Any description from claim 1 to claim 8 regarding two-component polyurethane composition that can be applied in orthopaedic treatment
AU2021103268A 2021-06-10 2021-06-10 Two-component polyurethane composition and its preparation method, and application thereof Ceased AU2021103268A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021103268A AU2021103268A4 (en) 2021-06-10 2021-06-10 Two-component polyurethane composition and its preparation method, and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2021103268A AU2021103268A4 (en) 2021-06-10 2021-06-10 Two-component polyurethane composition and its preparation method, and application thereof

Publications (1)

Publication Number Publication Date
AU2021103268A4 true AU2021103268A4 (en) 2021-07-29

Family

ID=76972114

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021103268A Ceased AU2021103268A4 (en) 2021-06-10 2021-06-10 Two-component polyurethane composition and its preparation method, and application thereof

Country Status (1)

Country Link
AU (1) AU2021103268A4 (en)

Similar Documents

Publication Publication Date Title
US8481801B2 (en) Fluid wound dressing comprising partially cured polyurethane
US4498467A (en) Orthopedic cast, device and method for forming same and package therefor
EP1562648B1 (en) Polyurethane foam dressing for wound filler and method for manufacturing thereof
EP0665856A1 (en) Hydrophilic polyurethane gel foams, particularly for treating deep wounds, wound dressing based on hydrophilic polyurethane gel foams and method of manufacture
US20210378875A1 (en) Wound contact surface and method of manufacture
JPH0226983B2 (en)
KR101731612B1 (en) Medical silicon adhesvie compositoin
CN108939128A (en) With medicament slow release and from the function and service dressing and preparation method thereof of antibacterial effect
CN113801285A (en) Preparation method of polyurethane foam dressing and wound dressing patch
EP0223380B1 (en) Reinforced casting material
AU2021103268A4 (en) Two-component polyurethane composition and its preparation method, and application thereof
CN106832206A (en) A kind of medical dressing material with cooling capacity and preparation method thereof
US20230192936A1 (en) Two-component polyurethane composition, and preparation method and application thereof
CN105056279A (en) Double-layer polyurethane-based collagen-compounded dressing
JPS62270161A (en) Rapid curable bandage tape
CN105944138A (en) Preparation method of biodegradable medical polyurethane and chitosan composite hemostatic sponge
CN101972488B (en) Preparation method of polyurethane gypsum
KR100249674B1 (en) A water-hardening polyureathane resin composition
RU2471506C1 (en) Polyurethane composition for preparing medical dressing
KR101494660B1 (en) Polyurethane Foam Dressing having improved adhesive property
EP1558300A1 (en) Fluid wound dressing comprising partially cured polyurethane
KR0167828B1 (en) Water dispersed curable polyurethane resin composition
KR100448098B1 (en) Resin composition of polyurethane hardening by moisture and cast for orthopedic surgery prepared therefrom
KR100428748B1 (en) Water-setting polyurethane resin composition for casting tape
KR100981440B1 (en) Water-curable polyurethane and sprint for orthopedice

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK22 Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry